Related Experiment Videos
[Functional analysis of phospholipase A2 receptor by gene knockout studies]
1Shionogi Research Laboratories, Shionogi & Co., Ltd., 5-12-4, Sagisu, Fukushima-ku, Osaka 553-0002, Japan.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan
|February 24, 2001
Summary
Phospholipase A2 receptor (PLA2R) deficiency protects mice from endotoxic shock by reducing inflammatory cytokines. A novel inhibitor, indoxam, also shows protective effects, highlighting PLA2R
Area of Science:
- Immunology
- Molecular Biology
Background:
- Phospholipase A2 receptor (PLA2R) is a transmembrane glycoprotein involved in biological responses to secretory phospholipase A2 (sPLA2).
- sPLA2-IB is a known ligand for PLA2R, mediating various cellular functions.
Purpose of the Study:
- To investigate the role of PLA2R in endotoxic shock.
- To identify novel ligands for PLA2R.
- To evaluate the therapeutic potential of sPLA2 inhibitors targeting PLA2R.
Main Methods:
- Generation and analysis of PLA2R-deficient mice.
- In situ hybridization to assess gene expression.
- Synthesis and testing of a specific sPLA2 inhibitor, indoxam.
- Detection and characterization of soluble PLA2R.
Main Results:
- PLA2R-deficient mice showed resistance to endotoxic shock with reduced TNF-alpha and IL-1 beta levels.
- sPLA2-X was identified as a high-affinity ligand for PLA2R.
- PLA2R deficiency reduced TNF-alpha expression in alveolar epithelial cells and splenic lymphocytes.
- Indoxam inhibited sPLA2 binding to PLA2R, reduced TNF-alpha, and improved survival in endotoxin-challenged mice.
- A soluble form of PLA2R was detected in plasma, potentially acting as an endogenous inhibitor.
Conclusions:
- PLA2R plays a critical role in the development of endotoxic shock.
- Targeting PLA2R with inhibitors like indoxam offers a potential therapeutic strategy for endotoxic shock.
- PLA2R mediates inflammatory responses, particularly TNF-alpha production, during endotoxic shock.